{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:17:25Z","timestamp":1793834245724,"version":"4.6.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.coi.2025.102636","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T09:26:17Z","timestamp":1755163577000},"page":"102636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Implication of epigenetic factors in development and recurrence of psoriasis"],"prefix":"10.1016","volume":"96","author":[{"given":"Jingyi","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erle","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5842-8080","authenticated-orcid":false,"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2025.102636_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41584-019-0175-0","article-title":"Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition","volume":"15","author":"Scher","year":"2019","journal-title":"Nat Rev Rheuma"},{"key":"10.1016\/j.coi.2025.102636_bib2","doi-asserted-by":"crossref","DOI":"10.2196\/resprot.8490","article-title":"Psychosocial distress of patients with psoriasis: protocol for an assessment of care needs and the development of a supportive intervention","volume":"7","author":"Zill","year":"2018","journal-title":"JMIR Res Protoc"},{"key":"10.1016\/j.coi.2025.102636_bib3","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.coi.2025.102636_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/s12348-020-00225-z","article-title":"Preventing relapse in non-infectious uveitis affecting the posterior segment of the eye - evaluating the 0.2\u2009\u03bcg\/day fluocinolone acetonide intravitreal implant (ILUVIEN\u00ae)","volume":"10","author":"Bodaghi","year":"2020","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.coi.2025.102636_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049822","article-title":"IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE)","volume":"11","author":"Eyerich","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.coi.2025.102636_bib6","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/art.42240","article-title":"Joint-specific memory and sustained risk for new joint accumulation in autoimmune arthritis","volume":"74","author":"Chang","year":"2022","journal-title":"Arthritis Rheuma Hoboken NJ"},{"key":"10.1016\/j.coi.2025.102636_bib7","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/ecco-jcc\/jjaa087","article-title":"Relapse from deep remission after therapeutic de-escalation in inflammatory bowel disease: a systematic review and meta-analysis","volume":"14","author":"Zhang","year":"2020","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.coi.2025.102636_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41586-022-04919-3","article-title":"Inflammatory memory and tissue adaptation in sickness and in health","volume":"607","author":"Naik","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.coi.2025.102636_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaci.2024.05.008","article-title":"Inflammatory memory in psoriasis: from remission to recurrence","volume":"154","author":"Francis","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2025.102636_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jid.2017.08.038","article-title":"Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3","volume":"138","author":"Boniface","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2025.102636_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.coi.2025.102636_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010641","article-title":"Resident memory T cells in human health and disease","volume":"7","author":"Clark","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2025.102636_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdermsci.2019.06.002","article-title":"Significance of IL-17A-producing CD8+CD103+ skin resident memory T cells in psoriasis lesion and their possible relationship to clinical course","volume":"95","author":"Kurihara","year":"2019","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.coi.2025.102636_bib14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bjd.17748","article-title":"CD8 resident memory T cells with interleukin 17A-producing potential are accumulated in disease-na\u00efve nonlesional sites of psoriasis possibly in correlation with disease duration","volume":"181","author":"Vo","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2025.102636_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7692024","article-title":"T helper cell subsets in clinical manifestations of psoriasis","volume":"2016","author":"Diani","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.coi.2025.102636_bib16","first-page":"3111","article-title":"Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis","volume":"192","author":"Cheuk","year":"2014","journal-title":"J Immunol Balt Md 1950"},{"key":"10.1016\/j.coi.2025.102636_bib17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/jid.2010.280","article-title":"Resolved psoriasis lesions retain expression of a subset of disease-related genes","volume":"131","author":"Su\u00e1rez-Fari\u00f1as","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2025.102636_bib18","article-title":"Defining patient-level molecular heterogeneity in psoriasis vulgaris based on single-cell transcriptomics","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102636_bib19","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1172\/JCI93396","article-title":"Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing \u03b1\u03b2 T cell clones","volume":"127","author":"Matos","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2025.102636_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.746145","article-title":"DNA methylation patterns in CD8+ T cells discern psoriasis from psoriatic arthritis and correlate with cutaneous disease activity","volume":"9","author":"Charras","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.coi.2025.102636_sbref21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1245876","article-title":"DNA methylation patterns in CD4+ T-cells separate psoriasis patients from healthy controls, and skin psoriasis from psoriatic arthritis","volume":"14","author":"Natoli","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102636_sbref22","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.jaci.2022.12.823","article-title":"Pellino-1 promotes intrinsic activation of skin-resident IL-17A-producing T cells in psoriasis","volume":"151","author":"Kim","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2025.102636_bib23","article-title":"A single-cell transcriptional gradient in human cutaneous memory T cells restricts Th17\/Tc17 identity","volume":"3","author":"Cook","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.coi.2025.102636_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01347","article-title":"Metabolic reprogramming and longevity of tissue-resident memory T cells","volume":"9","author":"Pan","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102636_bib25","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nature21379","article-title":"Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism","volume":"543","author":"Pan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.coi.2025.102636_bib26","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/CM9.0000000000003499","article-title":"Tissue-resident memory T cells and their function in skin diseases","volume":"138","author":"Chen","year":"2025","journal-title":"Chin Med J"},{"key":"10.1016\/j.coi.2025.102636_sbref27","first-page":"1701","article-title":"Epigenetic regulation of IL-23 by E3 ligase FBXW7 in dendritic cells is critical for psoriasis-like inflammation","volume":"211","author":"Song","year":"2023","journal-title":"J Immunol Balt Md 1950"},{"key":"10.1016\/j.coi.2025.102636_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93780-x","article-title":"Growth arrest and DNA damage-inducible proteins (GADD45) in psoriasis","volume":"11","author":"Rodr\u00edguez-Jim\u00e9nez","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2025.102636_bib29","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/bph.16254","article-title":"Ash1L ameliorates psoriasis via limiting neuronal activity-dependent release of miR-let-7b","volume":"181","author":"Du","year":"2024","journal-title":"Br J Pharm"},{"key":"10.1016\/j.coi.2025.102636_bib30","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202345","article-title":"Single-cell analysis of human skin identifies CD14+ type 3 dendritic cells co-producing IL1B and IL23A in psoriasis","volume":"218","author":"Nakamizo","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2025.102636_bib31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/exd.12710","article-title":"Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis","volume":"24","author":"Reich","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.coi.2025.102636_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1057839","article-title":"Genome-wide DNA methylation of Munro\u2019s microabscess reveals the epigenetic regulation in the pathogenesis of psoriasis","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102636_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107334","article-title":"DZ2002 alleviates psoriasis-like skin lesions via differentially regulating methylation of GATA3 and LCN2 promoters","volume":"91","author":"Chen","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.coi.2025.102636_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00795","article-title":"A reappraisal on the potential ability of human neutrophils to express and produce IL-17 family members in vitro: failure to reproducibly detect it","volume":"9","author":"Tamassia","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102636_bib35","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jaci.2016.07.025","article-title":"MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis","volume":"139","author":"Srivastava","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2025.102636_sbref36","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jid.2023.10.042","article-title":"Neutrophil-derived microRNA-1290 promotes keratinocyte proliferation in psoriasis","volume":"144","author":"Higashi","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2025.102636_bib37","article-title":"Sulforaphane ameliorates the severity of psoriasis and SLE by modulating effector cells and reducing oxidative stress","volume":"13","author":"Du","year":"2022","journal-title":"Front Pharm"},{"key":"10.1016\/j.coi.2025.102636_bib38","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.stem.2021.07.001","article-title":"Establishment, maintenance, and recall of inflammatory memory","volume":"28","author":"Larsen","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.coi.2025.102636_bib39","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nature24271","article-title":"Inflammatory memory sensitizes skin epithelial stem cells to tissue damage","volume":"550","author":"Naik","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.coi.2025.102636_bib40","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.jid.2020.12.031","article-title":"Assay for transposase-accessible chromatin using sequencing analysis reveals a widespread increase in chromatin accessibility in psoriasis","volume":"141","author":"Tang","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2025.102636_bib41","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-022-01250-6","article-title":"Chromatin accessibility and transcriptome integrative analysis revealed AP-1-mediated genes potentially modulate histopathology features in psoriasis","volume":"14","author":"Xu","year":"2022","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.coi.2025.102636_sbref42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054556","article-title":"Psoriatic resolved skin epidermal keratinocytes retain disease-residual transcriptomic and epigenomic profiles","volume":"24","author":"Ghaffarinia","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coi.2025.102636_bib43","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.stem.2022.07.006","article-title":"Wound healing, fibroblast heterogeneity, and fibrosis","volume":"29","author":"Talbott","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.coi.2025.102636_bib44","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149538","article-title":"Fibroblast pathology in inflammatory diseases","volume":"131","author":"Wei","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2025.102636_bib45","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s12016-024-08997-1","article-title":"Fibroblast: a novel target for autoimmune and inflammatory skin diseases therapeutics","volume":"66","author":"Chen","year":"2024","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.coi.2025.102636_sbref46","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-44994-w","article-title":"Single-cell analysis of psoriasis resolution demonstrates an inflammatory fibroblast state targeted by IL-23 blockade","volume":"15","author":"Francis","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2025.102636_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/cells10112840","article-title":"Fibroblast memory in development, homeostasis and disease","volume":"10","author":"Kirk","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.coi.2025.102636_bib48","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jid.2021.06.030","article-title":"ZFP36 family members regulate the proinflammatory features of psoriatic dermal fibroblasts","volume":"142","author":"Angiolilli","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2025.102636_sbref49","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jid.2022.09.004","article-title":"The p300\/CBP inhibitor A485 normalizes psoriatic fibroblast gene expression in vitro and reduces psoriasis-like skin inflammation in vivo","volume":"143","author":"Kim","year":"2023","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2025.102636_bib50","article-title":"The relapse of psoriasis: mechanisms and mysteries","volume":"2","author":"Tian","year":"2022","journal-title":"JID Innov Ski Sci Mol Popul Health"},{"key":"10.1016\/j.coi.2025.102636_bib51","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/hmg\/10.17.1793","article-title":"Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies","volume":"10","author":"Bowcock","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.coi.2025.102636_bib52","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jid.2015.12.029","article-title":"Epigenome-wide association analysis identified nine skin DNA methylation loci for psoriasis","volume":"136","author":"Zhou","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2025.102636_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-018-0541-9","article-title":"Epigenome-wide DNA methylation regulates cardinal pathological features of psoriasis","volume":"10","author":"Chandra","year":"2018","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.coi.2025.102636_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179294","article-title":"The role of epigenetic factors in psoriasis","volume":"22","author":"Dopytalska","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coi.2025.102636_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-03028-1","article-title":"EZH2-dependent epigenetic modulation of histone H3 lysine-27 contributes to psoriasis by promoting keratinocyte proliferation","volume":"11","author":"Zhang","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.coi.2025.102636_sbref56","doi-asserted-by":"crossref","DOI":"10.1111\/exd.70054","article-title":"RNA sequencing reveals the long non-coding RNA signature in psoriasis keratinocytes and identifies CYDAER as a long non-coding rna regulating epidermal differentiation","volume":"34","author":"Freisenhausen","year":"2025","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.coi.2025.102636_bib57","article-title":"AIM2 and psoriasis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102636_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CCID.S444265","article-title":"The LINC01176-miR-218-5p-IL-36G network is responsible for the pathogenesis of psoriasis by promoting inflammation","volume":"17","author":"Zhao","year":"2024","journal-title":"Clin Cosmet Invest Dermatol"},{"key":"10.1016\/j.coi.2025.102636_bib59","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/jdv.19492","article-title":"Serine deficiency exacerbates psoriatic skin inflammation by regulating S-adenosyl methionine-dependent DNA methylation and NF-\u03baB signalling activation in keratinocytes","volume":"38","author":"Meng","year":"2024","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"10.1016\/j.coi.2025.102636_bib60","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jdermsci.2024.10.004","article-title":"Genome-wide DNA methylation regulated by AHCY through SAM \/ SAH axis promotes psoriasis pathogenesis","volume":"116","author":"Liu","year":"2024","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.coi.2025.102636_bib61","article-title":"Aberrant promoter methylation of Wnt inhibitory factor-1 gene is a potential target for treating psoriasis","volume":"250","author":"Liu","year":"2023","journal-title":"Clin Immunol Orlando Fla"},{"issue":"4","key":"10.1016\/j.coi.2025.102636_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-05790-4","article-title":"LncRNA UCA1 promotes keratinocyte-driven inflammation via suppressing METTL14 and activating the HIF-1\u03b1\/NF-\u03baB axis in psoriasis","volume":"14","author":"Hu","year":"2023","journal-title":"Cell Death Dis"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525001128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525001128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T13:24:11Z","timestamp":1757337851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791525001128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":62,"alternative-id":["S0952791525001128"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2025.102636","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implication of epigenetic factors in development and recurrence of psoriasis","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2025.102636","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102636"}}